Unknown

Dataset Information

0

Pin1 inhibition potently suppresses gastric cancer growth and blocks PI3K/AKT and Wnt/?-catenin oncogenic pathways.


ABSTRACT: Gastric cancer is the second leading cause of cancer-related mortality and the fourth most common cancer globally. High intratumor heterogeneity of advanced gastric cancer poses great challenges to targeted therapy due to simultaneous activation of many redundant cancer-driving pathways. A central common signaling mechanism in cancer is proline-directed phosphorylation, which is further regulated by the unique proline isomerase Pin1. Pin1 inhibition exerts anticancer activity by blocking multiple cancer-driving pathways in some cancers, but its role in gastric cancer is not fully understood. Here we detected Pin1 protein expression in 1065 gastric cancer patients and paired normal tissues using immunohistochemistry and Western blot, and then examined the effects of Pin1 overexpression, and genetic and chemical Pin1 inhibition using Pin1 short hairpin RNA or small molecule inhibitor all-trans retinoic acid (ATRA) on tumorigenesis of human gastric cancer in vitro and in vivo, followed by biochemical analyses to elucidate Pin1 regulated oncogenic pathways. We found that Pin1 was significantly overexpressed in primary and metastasized tumors, with Pin1 overexpression being correlated with advanced stage and poor prognosis. Furthermore, whereas Pin1 overexpression promoted the transformed phenotype in immortalized and nontransformed human gastric cells, either genetic or chemical Pin1 inhibition in multiple human gastric cancer cells potently suppressed cell growth, G1/S transition and colony formation in vitro, as well as tumor growth in xenograft tumor models in vivo, which were further supported by downregulation of multiple key oncoproteins in PI3K/AKT and Wnt/?-catenin signaling pathways. These results not only provide the first evidence for a critical role of Pin1 in the tumorigenesis of gastric cancer but also suggest that targeting Pin1 using ATRA or other inhibitors offers an effective new therapeutic approach for treating advanced gastric cancer.

SUBMITTER: Zhang Z 

PROVIDER: S-EPMC6753380 | biostudies-literature | 2019 Aug

REPOSITORIES: biostudies-literature

altmetric image

Publications

Pin1 inhibition potently suppresses gastric cancer growth and blocks PI3K/AKT and Wnt/β-catenin oncogenic pathways.

Zhang Zhenzhen Z   Yu Weixing W   Zheng Min M   Liao Xinhua X   Wang Jichuang J   Yang Dayun D   Lu Wenxian W   Wang Long L   Zhang Sheng S   Liu Hekun H   Zhou Xiao Zhen XZ   Lu Kun Ping KP  

Molecular carcinogenesis 20190426 8


Gastric cancer is the second leading cause of cancer-related mortality and the fourth most common cancer globally. High intratumor heterogeneity of advanced gastric cancer poses great challenges to targeted therapy due to simultaneous activation of many redundant cancer-driving pathways. A central common signaling mechanism in cancer is proline-directed phosphorylation, which is further regulated by the unique proline isomerase Pin1. Pin1 inhibition exerts anticancer activity by blocking multipl  ...[more]

Similar Datasets

| S-EPMC6235341 | biostudies-literature
| S-EPMC3897473 | biostudies-literature
| S-EPMC5078082 | biostudies-literature
| S-EPMC9788236 | biostudies-literature
| S-EPMC7733797 | biostudies-literature
| S-EPMC4957947 | biostudies-literature
2010-06-08 | E-GEOD-14795 | biostudies-arrayexpress
| S-EPMC8905820 | biostudies-literature
| S-EPMC10373986 | biostudies-literature
| S-EPMC6855054 | biostudies-literature